Role of epigallocatechin gallate on in vitro model of methylglyoxal-induced amyloidogenesis
dc.authorscopusid | 24481574200 | |
dc.authorscopusid | 36247613400 | |
dc.authorscopusid | 24179414900 | |
dc.authorscopusid | 57194276918 | |
dc.contributor.author | Kucukgul, Altug | |
dc.contributor.author | Işgör, Mehmet Mustafa | |
dc.contributor.author | Cellat, Mustafa | |
dc.contributor.author | Ata, Hayrettin | |
dc.date.accessioned | 2024-09-19T15:43:29Z | |
dc.date.available | 2024-09-19T15:43:29Z | |
dc.date.issued | 2016 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Introduction: The study aimed to investigate the potential effects of epigallocatechin gallate (EG) on the reflux of methylglyoxal (MG)-induced amyloidogenesis in human glioblastoma (U87) cells. Materials and Methods: The effective concentrations of MG and EG were investigated via Trypan blue test. Glyoxalase-1 (GLO-1), ?-amyloid precursor protein (?APP), and Caspase 3 (Cas 3) expression levels were determined by quantitative real-time polymerase chain reaction and intracellular glutathione (GSH) contents of cells were measured. Results: MG at 250 ?M reduced viable cells by 33.4% as compared to control group. However, 5 ?M EG pre-treatment before MG prevented 22.4% of the cell loss caused by MG (P ? 0.05). MG stimulated ?APP and Caspase 3 levels by 4.13- and 3.46-fold; however, EG pre-treatment inhibited these increases by 1.76 and 3.09, respectively. In addition, EG pre-treatment increased GLO-1 levels by 3.71-fold and GSH levels by 2.30-fold according to MG group. Conclusion: EG demonstrated protective effect against cell death on U87 cells by suppressing amyloidogenic factors and apoptotic stimuli induced by MG. | en_US |
dc.identifier.endpage | S420 | en_US |
dc.identifier.issn | 0973-8398 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.scopus | 2-s2.0-85019543767 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | S414 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/14341 | |
dc.identifier.volume | 10 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | BRNSS Publication Hub | en_US |
dc.relation.ispartof | Asian Journal of Pharmaceutics | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Amyloidogenesis | en_US |
dc.subject | Epigallocatechin gallate | en_US |
dc.subject | In vitro | en_US |
dc.subject | Methylglyoxal | en_US |
dc.title | Role of epigallocatechin gallate on in vitro model of methylglyoxal-induced amyloidogenesis | en_US |
dc.type | Article | en_US |